4-methyl Erlotinib 14591 Vacuolin-1 inhibits autophagy by impairing

Vacuolin-1 inhibits autophagy by impairing lysosomal maturation via PIKfyve inhibition

Solubility: DMSO: 60 mg/mL(201

β-Secretase Inhibitor II is a β-Secretase inhibitor

NCC(O)C1=CC=C(O)C=C1

3-triazol-4-yl)-2-[2-(3-methoxyphenyl)acetyl]-2

4-methyl Erlotinib 14591 Vacuolin-1 inhibits autophagy by impairing4 methyl Erlotinib is an analog of erlotinib by the addition of a methyl group at the four position of the phenyl group. Erlotinib is a tyrosine kinase inhibitor which acts on the epidermal growth factor receptor (EGFR) . The epidermal growth factor receptor (EGFR) autocrine pathway has been important for cancer development and progression, including cell proliferation, apoptosis, angiogenesis, and metastatic spread . Erlotinib inhibits EGFR